These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 31287493)
1. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2. Zhang Z; Xiong R; Li C; Xu M; Guo M Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4. Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565 [TBL] [Abstract][Full Text] [Related]
3. High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. Jiang L; Wang W; Li G; Sun C; Ren Z; Sheng H; Gao H; Wang C; Yu H Cancer Chemother Pharmacol; 2016 Aug; 78(2):333-9. PubMed ID: 27329359 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183 [TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498. Jin G; Yang Y; Tuo G; Wang W; Zhu Z Neoplasma; 2020 Jul; 67(4):751-761. PubMed ID: 32305055 [TBL] [Abstract][Full Text] [Related]
6. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas. Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200 [TBL] [Abstract][Full Text] [Related]
7. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro. Tang Y; Yang P; Zhu Y; Su Y Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470 [TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA Taurine Upregulated Gene 1 (TUG1) Downregulation Constrains Cell Proliferation and Invasion through Regulating Cell Division Cycle 42 (CDC42) Expression Via MiR-498 in Esophageal Squamous Cell Carcinoma Cells. Wang Z; Liu J; Wang R; Wang Q; Liang R; Tang J Med Sci Monit; 2020 Mar; 26():e919714. PubMed ID: 32139664 [TBL] [Abstract][Full Text] [Related]
10. TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2. Xu C; Guo Y; Liu H; Chen G; Yan Y; Liu T Cell Biosci; 2018; 8():61. PubMed ID: 30519392 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways. Song K; Ma C; Maswikiti EP; Gu B; Wang B; Wang N; Jiang P; Chen H Mol Carcinog; 2024 Oct; 63(10):1892-1906. PubMed ID: 38923019 [TBL] [Abstract][Full Text] [Related]
12. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1. Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057 [TBL] [Abstract][Full Text] [Related]
13. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming. Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347 [TBL] [Abstract][Full Text] [Related]
14. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling. Zhou Q; Hu T; Xu Y J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma. Xu Y; Wang J; Qiu M; Xu L; Li M; Jiang F; Yin R; Xu L Tumour Biol; 2015 Mar; 36(3):1643-51. PubMed ID: 25366138 [TBL] [Abstract][Full Text] [Related]
16. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma. Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related]
18. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway. Li DJ; Shi M; Wang Z Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA. Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606 [TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway. Yu X; Huang M; Yang G Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]